B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsReiterationPrice Target
B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.
B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.